The mid-long term effect of conversion from cyclusporine to tacrolimus in patients with kidney transplantation
10.3760/cma.j.issn.0254-1785.2011.09.005
- VernacularTitle:肾移植受者将环孢素A转换为他克莫司治疗的三年疗效分析
- Author:
Fanyuan ZHU
;
Li ZENG
;
Yan WEN
;
Wenyu ZHAO
;
Yu CHEN
;
Xueyang ZHEN
;
Liming WANG
;
Youhua ZHU
- Publication Type:Journal Article
- Keywords:
Kidney transplantation;
Cyclosporine;
Tacrolimus;
Conversion treatment
- From:
Chinese Journal of Organ Transplantation
2011;32(9):527-530
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo verify the efficacy and safety of conversion from cyclosporine (CsA) to tacrolimus (Tac) in renal transplant recipients. MethodsThe clinical data of conversion from CsA to Tac in renal transplant recipients were retrospectively analyzed. In 97 patients undergoing kidney transplantation, there were 62 cases of chronic allograft nephropathy (CAN), 21 cases of refractory renal allograft rejection, 8 cases of hepatic impairment, and 6 cases of gingival overgrowth and hirsutism. The patients were followed up with renal function, hepatic function, blood fat, pressure,glucose,acute rejection incidence, patients/kidney survival rate,and adverse drug reaction for 3 years.ResultsThe renal function of patients with CAN and refractory acute rejection was greatly improved after conversion from CsA to Tac treatment at the first year (P＜0. 05) ,and steady at the 2nd or 3rd year. The conversion treatment could greatly improve the hepatic function of patients with dysfunction of liver, improve the gum hypertrophy and hypertrichosis results from CsA. The 1- and 3-year patients/kidney survival rate after conversion from CsA to Tac was 100 ％/97. 9 ％ and 100 ％/92. 8 ％, respectively. The conversion treatment showed a significantly lower degree of plasma cholesterol, low density lipoprotein, triglyceride, and blood pressure (P ＜ 0.05). Incidence of pathoglycemia, diarrhea or anepithymia,and tremor after conversion treatment was 13.4 ％ (13/97),2. 1％ (2/97) and 5. 2 ％ (5/97),respectively. There were no serious pulmonary infection and tumor during the observation period. ConclusionThe mid-long term effect of conversion from CsA to Tac in patients with kidney transplantation is safe and effective.
